Robert P Edwards Selected Research

Vaginal Neoplasms (Cancer, Vaginal)

1/2018	Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
1/2015	Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer.
5/2012	Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer.
2/2008	High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina.
10/2006	High-dose-rate interstitial brachytherapy for gynecologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert P Edwards Research Topics

Disease

66	Neoplasms (Cancer) 04/2022 - 12/2002
56	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 07/2004
18	Endometrial Neoplasms (Endometrial Cancer) 07/2019 - 08/2006
16	Carcinoma (Carcinomatosis) 04/2022 - 01/2004
16	Ovarian Epithelial Carcinoma 01/2021 - 01/2010
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2004
6	Endometriosis 12/2018 - 11/2009
5	Weight Loss (Weight Reduction) 09/2019 - 04/2014
5	Vaginal Neoplasms (Cancer, Vaginal) 01/2018 - 10/2006
5	Obesity 05/2017 - 04/2014
5	Inflammation (Inflammations) 05/2015 - 01/2002
4	Vulvar Neoplasms (Vulvar Cancer) 01/2019 - 04/2006
4	Ascites 11/2014 - 01/2011
3	Fallopian Tube Neoplasms 01/2020 - 07/2014
3	Adenocarcinoma 01/2019 - 04/2007
3	Morbid Obesity 05/2017 - 04/2014
3	Nausea 01/2016 - 07/2009
3	Infections 07/2009 - 01/2002
2	Fatigue 01/2022 - 11/2014
2	Disease Progression 01/2021 - 01/2015
2	Wound Infection (Wound Infections) 01/2017 - 04/2013
2	Vomiting 11/2014 - 07/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Constipation 01/2022
1	COVID-19 01/2021
1	Premature Birth (Birth, Premature) 01/2021
1	Margins of Excision 07/2019
1	Abdominal Obesity 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Death (Near-Death Experience) 09/2018
1	Hemorrhage 01/2018

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2005
11	PlatinumIBA 04/2022 - 02/2010
9	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 04/2007
7	Biological ProductsIBA 01/2018 - 10/2006
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 08/2010
6	Hormones (Hormone)IBA 01/2018 - 08/2012
6	Oral ContraceptivesIBA 01/2018 - 01/2002
5	Pharmaceutical PreparationsIBA 01/2019 - 02/2009
5	Interleukin-2 (IL2)IBA 08/2013 - 07/2004
4	Estrogens (Estrogen)FDA Link 12/2018 - 07/2012
4	AntibodiesIBA 09/2015 - 11/2009
4	belotecanIBA 02/2012 - 02/2009
4	VaccinesIBA 10/2009 - 05/2004
3	ChemokinesIBA 01/2022 - 07/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 07/2014
3	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2014
3	ProstaglandinsIBA 04/2016 - 12/2011
3	CytokinesIBA 11/2014 - 07/2013
3	Carboplatin (JM8)FDA LinkGeneric 07/2014 - 01/2004
3	InterleukinsIBA 08/2013 - 07/2004
3	Interleukin-12 (IL 12)IBA 08/2013 - 01/2002
3	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2012 - 12/2011
3	Prostaglandins EIBA 01/2012 - 11/2011
2	LigandsIBA 01/2022 - 12/2011
2	Immune Checkpoint InhibitorsIBA 12/2021 - 09/2015
2	Estrogen ReceptorsIBA 12/2018 - 07/2012
2	Estrogen Receptor alphaIBA 12/2018 - 07/2017
2	RNA (Ribonucleic Acid)IBA 01/2018 - 12/2014
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2017 - 03/2012
2	MicroRNAs (MicroRNA)IBA 01/2016 - 03/2013
2	Mucin-1 (CA 15-3 Antigen)IBA 09/2015 - 11/2009
2	Complement System Proteins (Complement)IBA 05/2015 - 12/2014
2	Glycoproteins (Glycoprotein)IBA 01/2014 - 11/2009
2	Fluorouracil (Carac)FDA LinkGeneric 04/2013 - 05/2008
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2012 - 11/2011
2	AntigensIBA 07/2011 - 11/2009
2	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2009 - 02/2009
1	taxaneIBA 04/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Everolimus FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Toll-Like Receptor 4IBA 01/2018
1	poly(I).poly(c12,U) (ampligen)IBA 01/2018
1	Poly I-CIBA 01/2018
1	Poly IIBA 01/2018
1	TNF Receptor-Associated Factor 3IBA 01/2018

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 04/2022 - 01/2004
21	Therapeutics 01/2020 - 07/2004
19	Brachytherapy 07/2019 - 08/2006
17	Radiotherapy 07/2019 - 04/2006
8	Hysterectomy 07/2019 - 04/2008
6	Neoadjuvant Therapy 04/2022 - 06/2011
6	Bariatric Surgery 09/2019 - 04/2014
6	Hyperthermic Intraperitoneal Chemotherapy 12/2018 - 04/2007
5	Immunotherapy 12/2021 - 08/2007
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2014 - 04/2006
3	Cytoreduction Surgical Procedures 01/2019 - 03/2008
3	Tubal Sterilization (Tubal Ligation) 01/2016 - 03/2011
3	Lymph Node Excision (Lymph Node Dissection) 01/2015 - 04/2008
2	Aftercare (After-Treatment) 11/2015 - 12/2014
2	Debridement 04/2013 - 05/2008
2	Catheters 03/2010 - 07/2009
1	Ambulatory Care (Outpatient Care) 01/2021
1	Vulvectomy 01/2019
1	Maintenance Chemotherapy 12/2018
1	Dilatation and Curettage 01/2018